About Haemonetics...A solid Company
Haemonetics Reports Fourth Quarter and Fiscal 2023 Results; Provides Fiscal 2024 Guidance Boston, MA, May 11, 2023 - Haemonetics Corporation (NYSE: HAE) reported financial results for its fourth quarter and fiscal 2023, which ended April 1, 2023: 4th Quarter 2023 Fiscal 2023 Revenue, increase $304 million, 15% $1.169 billion, 18% Organic1 revenue increase 17% 21% Earnings per diluted share $0.57 $2.24 Adjusted earnings per diluted share $0.77 $3.03 Cash flow from operating activities $80 million $273 million Free cash flow before restructuring and restructuring related costs $71 million $190 million 1Excludes the impact of currency fluctuation and strategic exits of product lines. Chris Simon, Haemonetics’ CEO, stated: “Our consistently strong results throughout our fiscal year reflect significant progress in accelerating our transformational growth. We are outperforming in a challenging economic environment and meeting the needs of our customers while positioning us for future growth and success.”
What about another ''BID'' at $ 3,50 or more in the coming weeks,?
Just be patient for a higher bid for an extra 25 % premium !